Research on Bladder Dysfunction: Treatment and Prognosis

Dear Colleagues,

Bladder dysfunction, also known as voiding dysfunction, is a broad term used to describe a variety of symptoms brought on by abnormal bladder storage and/or emptying. While receiving modest attention from researchers and healthcare providers, this health condition has a significant impact on patients' functional capacities and quality of life. The spectrum of bladder dysfunction broadens to encompass a variety of overactive and underactive bladder conditions, where the underlying pathologies can be attributed to neurogenic or anatomic causes, or functional when no clear neurogenic or anatomic disorder can be identified. Treatment strategies for bladder dysfunction may include, but are not limited to, physical or behavioral therapy, pharmacotherapy (such as antimuscarinics, beta-adrenergic agonists, alpha adrenoreceptor blockers, etc.), catheterization, neuromodulation, botulinum toxin injections, and surgeries.

Evidence on the long-term efficacy and tolerability of these treatment modalities is still evolving. Furthermore, longitudinal studies are still required to assess the prognosis of bladder dysfunction and its effects on patients' physical and emotional wellness. In order to showcase the importance of updating urologists on the recent advances in bladder dysfunction research, Medicina is launching this Special Issue.

We invite you to contribute your work on this subject. Particularly welcomed are reviews or original papers that discuss the research on the treatment and prognosis of bladder dysfunction. We also encourage you to submit articles presenting strong evidence on various techniques for treating bladder dysfunction.

Dr. Abubakr H. Mossa
Dr. Lysanne Campeau
Dr. Samer Shamout
Dr. Bilal Farhan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• bladder dysfunction
• overactive bladder syndrome
• neurogenic bladder
• voiding dysfunction
• detrusor underactivity
• beta3-adrenergic agonists
• botulinum toxin injection
• bladder catheterization